Bernardino
Miñana López
Consultor Médico
Clínica Universitaria de Navarra
Pamplona, EspañaPublikationen in Zusammenarbeit mit Forschern von Clínica Universitaria de Navarra (9)
2024
-
An Unexpected Seminal Vesicle Pitfall in PSMA PET
Clinical nuclear medicine, Vol. 49, Núm. 6, pp. e274-e275
-
First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies
Clinical Genitourinary Cancer
-
PARP inhibitors alone or in combination for prostate cancer
Therapeutic Advances in Urology, Vol. 16
2022
-
Comparison of surgical approaches to radical prostatectomy in our series beyond oncological and functional outcomes
Actas Urologicas Espanolas, Vol. 46, Núm. 5, pp. 275-284
2021
-
Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain
International Journal of Clinical Practice, Vol. 75, Núm. 8
2020
-
Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain
International Journal of Clinical Practice, Vol. 74, Núm. 11
2019
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
2018
-
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies
BJU International, Vol. 122, Núm. 6, pp. 1049-1065
-
Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice
Actas Urologicas Espanolas, Vol. 42, Núm. 4, pp. 238-248